{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-004128","form_type":"8-K","ticker":"DH","cik":"0001861795","company_name":"Definitive Healthcare Corp.","filed_at":"2023-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.234868+00:00","generated_at":"2026-06-19T03:23:32.103864+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Definitive Healthcare Q4 revenue up 31% to $60.6M; FY23 guidance implies 14% growth","bullets":["Q4 revenue $60.6M (+31% YoY); GAAP net income $6.7M vs loss $14.8M in Q4 2021.","Full year 2022 revenue $222.7M (+34%); GAAP net loss $22.3M vs $61.3M loss prior year.","Adjusted EBITDA Q4 $17.0M (28% margin); full year $63.7M (29% margin).","Q1 2023 revenue guidance $56.5-58.5M (median +15% YoY); FY2023 revenue $249-255M (+14% at midpoint).","Executive Chairman Jason Krantz base salary reduced to $1,000/week, granted 18,465 RSUs, no 2023 bonus; CEO/CFO/Chairman received cash bonuses for 2022 despite missing targets."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-004128","json":"https://secwatch.observer/filing/0000950170-23-004128.json","markdown":"https://secwatch.observer/filing/0000950170-23-004128.md","text":"https://secwatch.observer/filing/0000950170-23-004128.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861795/000095017023004128/0000950170-23-004128-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861795/000095017023004128/dh-20230216.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T03:23:32.103864+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"580b14ad5c02a5ebffa2bd378f7b99b1831fe9c2","claim":"Definitive Healthcare Corp. reported fourth quarter ended December 31, 2022 results: revenue $60.6 million, net income $6.7 million. Guidance initiated.","evidence_excerpt":"Fourth Quarter 2022 Financial Highlights: • Revenue was $60.6 million, an increase of 31% from $46.3 million in Q4 2021. • GAAP Net Income (loss) was $6.7 million, or 11% of revenue, compared to $(14.8) million, or 32% of revenue in Q4 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000095017023004128/0000950170-23-004128-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$60.6 million"},{"label":"Net income","value":"$6.7 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"dc3d34626a067c5f412e0f60cb67c01a7fcdee02","claim":"Definitive Healthcare Corp. reported full year ended December 31, 2022 results: revenue $222.7 million, net income $(22.3) million. Guidance initiated.","evidence_excerpt":"Full Year 2022 Financial Highlights: • Revenue was $222.7 million for the year, an increase of 34% from $166.2 million for the full year 2021. • GAAP Net loss was $(22.3) million, or 10% of revenue, compared to $(61.3) million, or 37% of revenue for the full year 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000095017023004128/0000950170-23-004128-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year ended December 31, 2022"},{"label":"Revenue","value":"$222.7 million"},{"label":"Net income","value":"$(22.3) million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}